J
Juan F. Ascaso
Researcher at University of Valencia
Publications - 233
Citations - 4656
Juan F. Ascaso is an academic researcher from University of Valencia. The author has contributed to research in topics: Insulin resistance & Diabetes mellitus. The author has an hindex of 27, co-authored 231 publications receiving 4123 citations. Previous affiliations of Juan F. Ascaso include Menéndez Pelayo International University & Carlos III Health Institute.
Papers
More filters
Journal ArticleDOI
Diferencias en las características clínico-biológicas y prevalencia de complicaciones crónicas en relación con el envejecimiento de pacientes con diabetes tipo 2
María Luisa Basanta-Alario,Jordi Ferri,Miguel Civera,Sergio Martínez-Hervás,Juan F. Ascaso,José T. Real +5 more
TL;DR: La edad se relaciono de forma inversa with parametros relacionados with el sindrome metabolico (IMC, perimetro de cintura, presion arterial y trigliceridos) and la prevalencia of sindrom metabolico es menor in los sujetos con DMT2 >70 anos.
Journal ArticleDOI
Increased thioredoxin levels are related to insulin resistance in familial combined hyperlipidaemia.
Sergio Martínez-Hervás,Ana Artero,Juncal Martinez-Ibañez,Mari C. Tormos,Herminia González-Navarro,Antonia Priego,Jose Martinez-Valls,Guillermo T. Sáez,José T. Real,Rafael Carmena,Juan F. Ascaso +10 more
TL;DR: Since FCH is associated with high risk of cardiovascular disease, the objective of the present study was to assess oxidative stress status in FCH patients, and evaluate the influence of insulin resistance (IR).
Journal ArticleDOI
Hipoglucemia grave y prolongada secundaria a cotrimoxazol en sujeto con factores predisponentes
Journal Article
Hipercolesterolemia familiar: identificación y caracterización molecular del primer homozigoto compuesto español
Francisco J Chaves,José T. Real,Oscar Puig,Juan F. Ascaso,José L. Teruel,Miguel A. Lasunción,Rafael Carmena,Maria E. Armengod +7 more
TL;DR: The first compound homozygous of FH in Spain is identified and characterized using the single strand conformational polymorphism (SSCP) analysis using a 30 years old female, who carried two different mutations in the LDL receptor gene: the G528V and the D280G (a new mutation).
Journal ArticleDOI
Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment (II). The treatment of nonalcoholic fatty liver disease.
Ángel Brea,Xavier Pintó,Juan F. Ascaso,Mariano Blasco,Ángel Díaz,Pedro González-Santos,Antonio Hernández-Mijares,Teresa Mantilla,Jesús Millán,Juan Pedro-Botet +9 more
TL;DR: The treatment of NAFLD and its influence on cardiovascular disease and drugs used in the control of cardiovascular risk factors showing a beneficial effect on the liver disease will be reviewed.